[1] |
McKay AJ, Gunn LH, Sathish T, et al. Associations between attainment of incentivised primary care indicators and incident diabetic retinopathy in England: a population-based historical cohort study [J]. BMC Med, 2021, 19(1): 93.
|
[2] |
Azegami T, Nakayama T, Hayashi K, et al. Vaccination against receptor for advanced glycation end products attenuates the progression of diabetic kidney disease [J]. Diabetes, 2021, 70(9): 2147-2158.
|
[3] |
郝艳,周志华. 血清胱抑素C与2型糖尿病视网膜病变及周围血管病变相关性分析[J]. 临床军医杂志,2020, 48(1): 84-86.
|
[4] |
吴泽丹,吴京,陈林江,等. 血清胱抑素C水平与2型糖尿病患者视网膜血管直径的相关性研究[J]. 中国全科医学,2020, 23(15): 1895-1903.
|
[5] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志,2018, 38(4): 292-344.
|
[6] |
中华医学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014年)[J]. 中华眼科杂志,2014, 50(11): 851-865.
|
[7] |
中华医学会内分泌学分会. 中国成人糖尿病肾脏病临床诊断的专家共识[J]. 2016, 10(6): 243-253.
|
[8] |
刘蕾. 血尿酸在糖尿病视网膜病变合并糖尿病肾病患者血清中的表达及其意义[J]. 医学临床研究,2020, 37(8): 1256-1258.
|
[9] |
Hu Y, Chan Z, Li C, et al. Higher serum uric acid levels are associated with an increased risk of vision-threatening diabetic retinopathy in type 2 diabetes patients [J]. Invest Ophthalmol Vis Sci, 2021, 62(4): 23.
|
[10] |
梁冬蕊,李晓东,付燕,等. 糖尿病肾病患者合并糖尿病视网膜病变的危险因素研究[J]. 临床肾脏病杂志,2022, 22(5): 370-374.
|
[11] |
张威,袁伟杰,陈博,等. ADMA-DDAH路径在尿酸引起血管内皮损伤中的作用[J]. 中华肾脏病杂志,2011, 27(1): 17-22.
|
[12] |
Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk [J]. Ann Biol Clin ( Paris), 2010, 68(5): 517-529.
|
[13] |
Ahuja S, Ahuja-Jensen P, Johnson LE, et al. Rdl mouse retina shows an imbalance in the activity of cysteine protease cathepsins and their endogenous inhibitor cystatin C [J]. Invest Ophthalmol Vis Sci, 2008, 49(3): 1089-1096.
|
[14] |
毛维维. 血清胱抑素C水平对糖尿病视网膜病变合并糖尿病肾病的诊断价值[J]. 医学临床研究,2021, 38(4): 619-621.
|
[15] |
陈玉洁. 血清Cys-C,VEGF,CA153在乳腺癌诊断中的价值[J]. 检验医学与临床,2022, 19(5): 591-593, 598.
|
[16] |
浦丹凤,王霞娟,马坚,等. 糖尿病视网膜病变合并糖尿病肾病的危险因素及其预测价值[J]. 中华老年多器官疾病杂志,2019, 18(1): 30-35.
|